🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Venous Thromboembolism (VTE)

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer NCT07288632n/a1 site📍 Perugia University Of Perugia Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery NCT07439991n/a1 site📍 Changchun The First Hospital of Jilin University · Tests: Prospective Perioperative Data Collection Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis NCT06958588Phase 41 site📍 Belo Horizonte Science Valley Research Institute · Tests: Experimental: Hyperslim, Active Comparator #1 Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) NCT03728166NA1 site📍 Boston Brigham and Women's Hospital · Tests: Electronic alert Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients NCT07856641n/a1 site📍 Houston The University of Texas Health Science Center, Houston PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) NCT03559114Phase 312 sites📍 Calgary📍 Edmonton📍 Edmonton Sunnybrook Health Sciences Centre · Tests: Dalteparin, Saline Heat Shock Protein 47 in Thrombosis NCT06731673n/a2 sites📍 Aarhus📍 Berlin University of Aarhus Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies NCT07270263NA1 site📍 Gdansk Medical University of Gdansk · Tests: Apixaban, Rivaroxaban, low molecular weight heparin (enoxaparin sodium) Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable NCT07430956Phase 344 sites📍 Dothan📍 Glendale📍 Little Rock Regeneron Pharmaceuticals · Tests: REGN7508, REGN9933, Placebo RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing NCT06195540Phase 337 sites📍 Agen📍 Angers📍 Argenteuil University Hospital, Angers · Tests: Rivaroxaban 10 MG, Low Heparin Molecular Weight Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial NCT06523959Phase 41 site📍 Helsinki Clinical Urology and Epidemiology Working Group · Tests: Apixaban 2.5 MG Padua Prediction Score for VTE Risk in Thoracic Surgery Patients NCT06732726n/a1 site📍 Baghdad Al-Nahrain University VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy NCT05920343Phase 2, Phase 31 site📍 Ottawa Ottawa Hospital Research Institute · Tests: Rivaroxaban 10 MG, Placebo control REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults NCT07015905Phase 347 sites📍 Sheffield📍 Riverside📍 Englewood Regeneron Pharmaceuticals · Tests: REGN7508, Apixaban, Enoxaparin, Placebo Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study NCT07196020n/a3 sites📍 Cork📍 Dublin📍 Dublin University of Dublin, Trinity College The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer NCT06861088Phase 33 sites📍 Ventura📍 Miami Lakes📍 Boston Quercis Pharma AG · Tests: Kinisoquin™, Placebo Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study) NCT07372716NA1 site📍 Ottawa Ottawa Hospital Research Institute · Tests: standardized perioperative anticoagulation management Guideline Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk NCT06845423Phase 418 sites📍 Amiens📍 Bordeaux📍 Brest University Hospital, Brest · Tests: Low molecular weight heparin Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism NCT06393868Phase 37 sites📍 Ottawa📍 St. Catharines📍 Toronto Ottawa Hospital Research Institute · Tests: Omeprazole 20 mg Oral Tablet, Placebo Aspirin vs. Rivaroxaban for Thromboprophylaxis in Multiple Myeloma NCT07907211Phase 41 site📍 Nanjing Chen Lijuan · Tests: Aspirin, Rivaroxaban Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis NCT07140211Phase 39 sites📍 Baden📍 Basel📍 Bern Marc Blondon · Tests: Low-dose low-molecular-weight heparin Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism NCT07143539NA6 sites📍 Aarau📍 Baden📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Exercise-based rehabilitation program A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection NCT07786779Phase 11 site📍 Beijing Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. · Tests: YKYY033 Injection, YKYY033 Placebo NOACs Use in AF or VTE (SUNSHINE Registry) NCT05378308n/a1 site📍 Zhengzhou Henan Provincial People's Hospital · Tests: Patients with Atrial Fibrillation (AF) or venous thromboembolism (VTE) REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis NCT07410117Phase 323 sites📍 Hialeah📍 North Miami Beach📍 New York Regeneron Pharmaceuticals · Tests: REGN7508, Placebo External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients NCT07310693n/a12 sites📍 Barcelona📍 Madrid📍 Madrid Infanta Leonor University Hospital Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers NCT07493304Phase 313 sites📍 Hialeah📍 New York📍 El Paso Regeneron Pharmaceuticals · Tests: REGN7508, Apixaban AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial. NCT06939803NA1 site📍 Nashville Vanderbilt University Medical Center · Tests: Risk model-driven CDS Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam NCT07083609n/a1 site📍 Hanoi Hieu Trung Dinh · Tests: Dabigatran, Rivaroxaban Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis NCT06603870Phase 42 sites📍 Ottawa📍 Sault Ste. Marie Ottawa Hospital Research Institute · Tests: Anticoagulation Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy